CytoDyn Inc. (CYDY) income statement
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn Inc. income statement
Ratios
Latest available, balances at Aug 31, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- 41.5%
Financial strength
- Current ratio
- 0.38
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 32.9%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?